Photodynamic Therapy in Ocular Oncology
Open Access
- 7 February 2018
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 6 (1) , 17
Abstract
Although introduced for the treatment of maculopathies, photodynamic therapy (PDT) is now largely used in some eye cancers treatment. The selective tissue damage with PDT is achieved by sequestration of the photosensitizer in the target tissue and focal activation of the photosensitizer by low energy directed light. In this way, it is possible to achieve the destruction of the tumor tissue by safeguarding the surrounding healthy structures. Our study describes the clinical uses and efficacy of photodynamic therapy in ocular oncology.Keywords
This publication has 38 references indexed in Scilit:
- CLINICAL AND HISTOPATHOLOGIC FINDINGS AFTER PHOTODYNAMIC THERAPY OF CHOROIDAL MELANOMARetina, 2012
- Blurred vision due to choroidal metastasis as the first manifestation of lung cancer: A case reportWorld Journal of Surgical Oncology, 2010
- Vasoproliferative retinal tumours in a Swedish populationActa Ophthalmologica, 2009
- Management of metastatic carcinoma of the uveal tract: an evidence‐based analysisClinical & Experimental Ophthalmology, 2007
- Photodynamic Therapy With Verteporfin of Choroidal Malignancy From Breast CancerAmerican Journal of Ophthalmology, 2006
- Photodynamic therapy for choroidal metastasis from lung adenocarcinomaActa Ophthalmologica Scandinavica, 2006
- Incidence of noncutaneous melanomas in the U.S.Cancer, 2005
- Photodynamic therapy for choroidal metastasis from carcinoid tumorAmerican Journal of Ophthalmology, 2004
- Efficacy of photodynamic therapy in circumscribed choroidal haemangiomaEye, 2004
- Peripheral retinal angioma with exudative retinopathy in adults (coats's lesion).British Journal of Ophthalmology, 1966